Certified by Founder Lodge
Aperiam Bio
United States - Brooklyn, New York
START UP
1 Disclosed Funding Rounds $9,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Aperiam is building hyperfolding enzymes with deep learning algorithms that understand protein chemistry.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 30 ,2023 | Seed | $9,000,000 |
KdT Ventures
Civilization Ventures
OMX Ventures
Axial
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
